Fisher & Paykel Healthcare Corp Ltd FSPKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $26.01
- Day Range
- $25.81–25.81
- 52-Week Range
- $19.01–26.53
- Bid/Ask
- $25.22 / $29.80
- Shares Outstanding
- 588.27M
- Market Cap
- $15.16B
- Volume/Avg
- 1,000 / 6,643
Key Statistics
- Price/Earnings (Normalized)
- 55.04
- Price/Sales
- 11.26
- Dividend Yield (Trailing)
- 1.15%
- Dividend Yield (Forward)
- 1.15%
- Dividend Payment Schedule
- Jul, Dec
- Total Yield
- 1.15%
Company Profile
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 7,375
- Website
- https://www.fphcare.com
Competitors
Valuation
|
Metric
|
FSPKF
|
CTEC
|
COLO B
|
|---|---|---|---|
Price/Earnings (Normalized) | 55.04 | 22.65 | 33.56 |
Price/Book Value | 12.54 | 3.99 | 7.35 |
Price/Sales | 11.26 | 2.36 | 3.45 |
Price/Cash Flow | 39.19 | 12.72 | 12.54 |
Price/Earnings
FSPKF
CTEC
COLO B
Financial Strength
|
Metric
|
FSPKF
|
CTEC
|
COLO B
|
|---|---|---|---|
Quick Ratio | 1.59 | 1.06 | 0.88 |
Current Ratio | 2.31 | 1.93 | 1.56 |
Interest Coverage | 61.51 | 3.34 | 6.65 |
Quick Ratio
FSPKF
CTEC
COLO B
Profitability
|
Metric
|
FSPKF
|
CTEC
|
COLO B
|
|---|---|---|---|
Return on Assets (Normalized) | 17.34% | 9.54% | 11.86% |
Return on Equity (Normalized) | 23.25% | 22.72% | 38.99% |
Return on Invested Capital (Normalized) | 21.70% | 13.15% | 15.76% |
Return on Assets
FSPKF
CTEC
COLO B
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|$PCq?$Rn | LOCK|Q>& | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|$t | LOCK|n^Ypb | $50B | |||
| ResMed Inc
RMD
| LOCK|v<v^C&&^ | LOCK|$g#Df | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|w%bSQ? | LOCK|YLFdj | $32B | |||
| Alcon Inc
ALC
| LOCK|#&>^n! | LOCK|^q>< | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|@m!&#S! | LOCK|g!& | $26B | |||
| Solventum Corp
SOLV
| LOCK|$KPMlv | LOCK|dP? | $15B | |||
| Baxter International Inc
BAX
| LOCK|g^$ | LOCK|l&hf | $13B | |||
| Repligen Corp
RGEN
| LOCK|L!M$n%G^ | LOCK|!CBjq | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|@fwRtz$ | LOCK|^!^lv | $10B |
United States